Acute zonal occult outer retinopathy

Photopsia manifests as flashes of light that occur in the peripheral vision. This symptom is caused by abnormal electrical activity in the retina, often due to inflammation or damage to the photoreceptor cells. Over time, photopsia may become more frequent or intense, potentially indicating progression of the underlying condition. It can be disruptive to daily activities, especially in low-light conditions, and management may include monitoring and addressing the underlying retinal changes.

Visual field loss presents as a reduction in the peripheral or central vision, often described as 'blind spots'. This occurs due to damage to the outer retina, particularly affecting the photoreceptor layer. The progression can be gradual or sudden, leading to significant impairment if not addressed. It affects daily life by limiting the ability to perform tasks that require a full field of vision, such as driving, and management includes regular monitoring and potential therapeutic interventions.

Decreased visual acuity is experienced as a reduction in the sharpness or clarity of vision. This symptom results from damage to the photoreceptors and the subsequent disruption in the transmission of visual signals to the brain. Over time, the decrease in visual acuity can worsen, particularly if the underlying condition progresses. It impacts daily activities such as reading and recognizing faces, and management strategies may include corrective lenses and addressing the underlying retinal changes.

Metamorphopsia is perceived as a distortion of visual images, where straight lines may appear wavy or bent. This occurs due to irregularities in the retinal surface or photoreceptor alignment. The symptom can fluctuate in severity, often correlating with the activity of the underlying retinal condition. It affects tasks requiring precise visual perception, such as reading or driving, and management may involve monitoring and treating the retinal abnormalities.

Scotomas are areas of partial alteration in the visual field, often perceived as dark or blurry spots. They result from localized damage to the retina, particularly affecting the photoreceptor cells. Over time, scotomas may enlarge or increase in number, indicating progression of retinal damage. They interfere with daily activities by obstructing parts of the visual field, and management includes regular eye examinations and addressing the underlying cause.

Nyctalopia, or night blindness, is characterized by difficulty seeing in low-light conditions. This symptom arises from impaired function of the rod photoreceptors, which are responsible for vision in dim lighting. The condition may worsen over time if the retinal damage progresses, leading to increased difficulty in navigating in the dark. It affects activities such as driving at night, and management may involve lifestyle adjustments and addressing the underlying retinal issues.

Color vision changes manifest as difficulty in distinguishing between different colors or noticing a dulling of colors. This occurs due to dysfunction in the cone photoreceptors, which are responsible for color vision. The changes can progress slowly, potentially leading to more pronounced color discrimination issues. It can impact activities that rely on accurate color perception, such as selecting clothing or identifying traffic lights, and management may include monitoring and addressing the retinal condition.

Floaters are perceived as small, shadowy shapes that drift across the visual field. They are caused by changes in the vitreous humor or retinal surface, often related to retinal detachment or degeneration. Over time, floaters may increase in number or size, particularly if the underlying condition progresses. They can be distracting during activities that require focused vision, such as reading, and management may involve monitoring and potential surgical intervention if they significantly impair vision.

The clinician evaluates the patient for sudden visual field loss and photopsia, which are hallmark symptoms. A detailed history of any recent viral infections or autoimmune disorders is taken, as these can be relevant. Physical examination includes checking for relative afferent pupillary defect and visual acuity. This step helps differentiate AZOOR from other retinal or neuro-ophthalmic conditions.

Optical coherence tomography (OCT) is the primary imaging modality used to assess the retina. It reveals outer retinal layer disruptions, which are characteristic of AZOOR. These findings help confirm the diagnosis by showing photoreceptor layer damage. Imaging also helps exclude other conditions like optic neuritis or retinal detachment.

Blood tests may be ordered to check for inflammatory markers or autoimmune antibodies. Elevated levels of these biomarkers can suggest an autoimmune etiology. Abnormal results guide the clinician towards considering immunosuppressive therapy. Laboratory tests also help rule out infectious causes of retinal damage.

Genetic testing may involve sequencing genes associated with retinal dystrophies. Mutations in genes like RHO or RPGR can be found in some cases. Positive results confirm a genetic predisposition to AZOOR and aid in genetic counseling. This information is valuable for advising family members about potential risks.